Bile Acid Receptor Therapeutics Effects on Chronic Liver Diseases

by Vik Meadows, Vik Meadows, Lindsey Kennedy, Debjyoti Kundu, Gianfranco Alpini, Gianfranco Alpini, Heather Francis, Heather Francis
Published 2020-01-01

Alcoholic liver disease and mast cells: What's your gut got to do with it?

by Julie Ann Tolefree, Abigail Joy Garcia, Jenee Farrell, Vik Meadows, Lindsey Kennedy, Laura Hargrove, Jennifer Demieville, Nicole Francis, Julia Mirabel, Heather Francis
Published 2019-03-01

Feedback Signaling between Cholangiopathies, Ductular Reaction, and Non-Alcoholic Fatty Liver Disease

by Tianhao Zhou, Debjyoti Kundu, Jonathan Robles-Linares, Vik Meadows, Keisaku Sato, Leonardo Baiocchi, Burcin Ekser, Shannon Glaser, Gianfranco Alpini, Heather Francis, Lindsey Kennedy
Published 2021-08-01

Cyclic AMP Signaling in Biliary Proliferation: A Possible Target for Cholangiocarcinoma Treatment?

by Leonardo Baiocchi, Ilaria Lenci, Martina Milana, Lindsey Kennedy, Keisaku Sato, Wenjun Zhang, Burcin Ekser, Ludovica Ceci, Vik Meadows, Shannon Glaser, Gianfranco Alpini, Heather Francis
Published 2021-07-01

Knockdown of vimentin reduces mesenchymal phenotype of cholangiocytes in the Mdr2−/− mouse model of primary sclerosing cholangitis (PSC)Research in context

by Tianhao Zhou, Konstantina Kyritsi, Nan Wu, Heather Francis, Zhihong Yang, Lixian Chen, April O'Brien, Lindsey Kennedy, Ludovica Ceci, Vik Meadows, Praveen Kusumanchi, Chaodong Wu, Leonardo Baiocchi, Nicholas J. Skill, Romil Saxena, Amelia Sybenga, Linglin Xie, Suthat Liangpunsakul, Fanyin Meng, Gianfranco Alpini, Shannon Glaser
Published 2019-10-01